As of April 14, 2014, there are 12 people on AIDS Drug Assistance Program (ADAP) waiting list.

ADAP Watch

April 22, 2014 
As of April 14, 2014, there are 12 people on AIDS Drug Assistance Program (ADAP) waiting list. 
  • Ten ADAPs have had cost-containment measures in place since April 1, 2013 (reported as of April 7, 2014).
  • Alaska and Louisiana report considering implementing new or additional cost-containment measures by the end of ADAP’s current fiscal year (March 31, 2015).

ADAPs with Current or Anticipated Cost-Containment Measures, Including Waiting Lists, as of April 14, 2014

ADAPs with Current or Anticipated Cost-Containment Measures, Including Waiting Lists, as of April 14, 2014

ADAPs with Waiting Lists
(12 individuals in 1 state, as of April 14, 2014)


Number of Individuals on ADAP Waiting List

Percent of the Total
ADAP Waiting List

Increase/Decrease from Previous Reporting Period

Date Waiting List Began





February 2014

Waiting List Organization: Waiting list clients are prioritized by one of two models:
  • First-come, first-served model:  placing individuals on the waiting list in order of receipt of a completed application and eligibility confirmation (0 ADAPs).
  • Medical criteria model:  based on hierarchical medical criteria based on recommendations by the ADAP Advisory Committee (1 ADAP). 
Access to Medications: Utah confirms that case management services assist clients in obtaining medications through the HarborPath ADAP waiting list program or pharmaceutical company patient assistance programs (PAPs) while clients are on the waiting list.
Latest ADAP News
The Consolidated Appropriations Act 2014 established FY2014 funding levels for the remainder of the federal fiscal year. While some sequestration cuts were alleviated, funding was not restored to pre-sequestration FY2012 levels. ADAP received a $14 million increase over FY2013. The total ADAP funding includes the President’s World AIDS Day 2011 increase of $35 million in ADAP emergency relief funding (ERF) in the ADAP budget authority. Hold harmless provisions were not extended; meaning the formula used for ADAP and Part B base FY2014 awards will not include a hold harmless protection. The Health Resources and Services Administration (HRSA) has released partial awards to ADAPs to begin their FY2014 grant year (April 1, 2014) due to the late timing of the final FY14 appropriations bill. HRSA indicates that the remainder of the funding will be granted to states within the next several months.

ADAPs with Other Cost-containment Strategies
(since April 1, 2013i, as of April 7, 2014)

Enrollment Cap

Expenditure Cap

Financial Eligibility

Formulary Reduction


Arizona: (monthly: insurance premiums of $350); (annual: medical copayment of $3000)
Illinois: (monthly)
South Dakota:  (annual)
Georgia: cap on insurance premiums

Montana: service reductions in place

iADAPs may have other cost-containment strategies that were instituted prior to April 1, 2013.

 ADAPs Considering New/Additional Cost-containment Measures
(before March 31, 2015


Enrollment Cap

Formulary Reduction

Waiting List

Louisiana Alaska Louisiana

iiMarch 31, 2015 is the end of ADAP FY2014. ADAP fiscal years begin April 1 and end March 31.

 ADAPs that Eliminated/Modified Cost-containment Measures
(since April 1, 2013
iii as of April 7, 2014)

Enrollment Cap

Expenditure Cap

Formulary Reduction



New Mexico


Oklahoma: increase financial eligibility to
400% for individuals with
insurance; 200% for uninsured.
Washington: stopped requiring use
of PAPs during insurance enrollment

iiiADAPs may have other cost-containment strategies that were eliminated/modified prior to
April 1, 2013.

About ADAP: ADAPs provide life-saving HIV treatments through directly purchasing medications or providing insurance coverage and wrap-around services to low income, uninsured, and underinsured individuals living with HIV/AIDS in all states, territories and associated jurisdictions.

About PAPs: Uninsured or underinsured individuals living with HIV who are ineligible for ADAPs can access needed medications using the common patient assistance program (PAP) application form to apply for multiple PAPs. To see additional information on pharmaceutical company patient assistance or co-payment assistance programs, please visit the Positively Aware website or the Fair Pricing Coalition's website. In addition, the HarborPath program is available to serve individuals on ADAP waiting lists as well as individuals in select states (see the HarborPath website for more information). 

About NASTAD: NASTAD strengthens state and territory-based leadership, expertise, and advocacy and brings them to bear on reducing the incidence of HIV and viral hepatitis and on providing care and support to all who live with HIV and viral hepatitis. NASTAD’s vision is a world free of HIV/AIDS and viral hepatitis. For more information, visit To receive or unsubscribe from The ADAP Watch, please contact Christopher Cannon.

like us on Facebook | follow us on Twitter | view us on YouTube | read our Blog | forward to a friend 

Copyright © 2014 NASTAD, All rights reserved.